Clinical Trial

Bronchoscopic Levofloxacin, Gentamicin, or Sham for Acute Exacerbation of Bronchiectasis

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2025 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Randomized single-center trial evaluating whether bronchoscopic instillation of levofloxacin or gentamicin improves outcomes compared to a sham bronchoscopic procedure in adult ICU patients with non-cystic fibrosis bronchiectasis requiring invasive mechanical ventilation. The primary outcome is a ranked composite of in-hospital mortality and time to ventilator liberation. Safety and procedural adverse events are closely monitored.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-13; most recent amendment 2025-07-13.
Status change: Not Yet Recruiting → Recruiting 2024-08-03
Trial Details
NCT Number NCT06209047
Lead Sponsor Assiut University
Conditions Bronchiectasis With Acute Exacerbation
Enrollment 315 participants
Start Date 2023-10-15
Primary Completion 2026-05-15 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-17